- Product Description Description
- Table of Contents TOC
- List of Table & Figure LOT
- Get Free Sample PDF Sample PDF
Market Size, 2025
$864 MnMarket Estimate, 2026
$932.69 MnMarket Forecast, 2034
$1,720 MnCAGR, 2026–2034
7.95%Executive Summary: Asia-Pacific Prefilled Syringes Market
- Market Scope: Comprehensive analysis of the Asia-Pacific prefilled syringes sector, evaluating material variants, syringe types, chamber designs, therapeutic applications, and country-level landscapes.
- Market Valuation: Valued at USD 864.00 million in 2025, reaching USD 932.69 million in 2026, and projected to expand to USD 1,720.00 million by 2034, progressing at a steady CAGR of 7.95% from 2026 to 2034.
- Primary Growth Drivers: Rising prevalence of chronic ailments like diabetes, expanding geriatric demographics, growing demand for self-administration and home healthcare, and high bioavailability advantages of injectable drug deliveries.
Key Market Segment Metrics
| Category | Leading Segment (Base Year Position) | Fastest-Growing / High-Impact Segment |
|---|---|---|
| By Material | Glass Prefilled Syringes (dominant traditional share favored for high chemical inertness and widespread biopharmaceutical compatibility) | Plastic Prefilled Syringes (high-growth segment driven by shatter-proof safety and self-administration preferences) |
| By Type | Conventional Prefilled Syringes (anchoring primary vaccination and routine hospital drug administration programs) | Safety Prefilled Syringes (expanding rapidly due to needle-stick injury prevention mandates and regulatory safety protocols) |
| By Application | Vaccines & Monoclonal Antibodies (major revenue pillars driven by immunization drives and biologic therapy adoption) | Self-Injection Therapies (high-impact sector fueled by chronic disease home-care management) |
Major Market Players & Market Structure
Market Structure: Highly competitive landscape featuring global medical packaging conglomerates and prominent domestic manufacturers focusing on technological innovations, dual-chamber designs, and regional manufacturing expansions.
Key Companies: Becton Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Vetter Pharma International GmbH, Ompi, Weigao Group, and Nipro Corporation.
Asia-Pacific Prefilled Syringes Market Size
The prefilled syringes market size in the Asia-Pacific was valued at USD 864 million in 2025. The market size in Asia-Pacific is expected to experience a CAGR of 7.95% from 2026 to 2034 and be worth USD 1,720 million by 2034 from USD 932.69 million in 2026.
MARKET DRIVERS
The Asia-Pacific region is presently dominating the global prefilled syringe market due to rising chronic diseases and the increasing aged population. The prefilled syringes market in the Asia Pacific is rising due to the advanced development of in-home healthcare and the benefits of using a traditional prefilled syringe globally. The growing usage of injectable dosage forms is further promoting the growth rate of the Asia-Pacific market. Also, increasing demand for self-administrated and self-injection for higher bioavailability is driving the prefilled syringe market. In addition, the rising aged population and an increasing number of people with diabetes are fuelling the market growth.
MARKET RESTRAINTS
However, several new drug delivery methods have come up in the market, and stringent government regulations hamper the market's growth.
SEGMENT ANALYSIS
By Material Insights
GEOGRAPHICAL ANALYSIS
The Asia Pacific is one of the most revenue-generating markets for prefilled syringes worldwide. The main reason for the highest growth rate exhibited by Asia-Pacific in the forecast is that this market is at a nascent stage and is ripe for investment with a massive potential for growth. Japan accounts for the majority share both in terms of volume and revenue.
India is one of the most lucrative regional markets in the Asia-Pacific region and is predicted to do well during the forecast period. India has many medical device manufacturing companies that import material, which is almost 75 % of total sales. In that, 60 % of the market is occupied by syringes. In 2022, Dr. Reddy introduced a new single-dose prefilled syringe after US Food and Drug Administration approval.
China had the most significant share in the Asia-Pacific market in 2025 and is estimated to register a healthy CAGR during the forecast period. According to WHO, the number of Type 2 diabetes patients in China has doubled in the last two decades, and currently, 110 million people have diabetes in China, according to WHO. US Food and Drug Administration approved Enbrel prefilled syringe in China to treat spondylitis.
Japan is expected to account for a substantial share of the Asia-Pacific market during the forecast period. An increasing aged population in Japan and growing demand for double chamber prefilled syringes in the market are leveling up the growth of the prefilled syringe market. The Parenteral Drug Association (PDA) Japan has initiated syringe self-administration to help biopharma and biotech companies with clinical trials and their basic needs, driving the Japanese prefilled syringe market.
South Africa is considered one of the hotspots in the APAC region and is forecasted to register a healthy CAGR over the forecast period. The development in the healthcare sector and growing demand for advanced prefilled syringes are driving the South Korean prefilled syringe market. SK Bioscience launched a new advanced Shingles vaccine in a prefilled syringe that provides water for injection to reduce the steps of the conventional vial formulation.
KEY MARKET PARTICIPANTS
A few prominent companies operating in the APAC Prefilled Syringes Market profiled in this report are Becton Dickinson and Company, Gerresheimer AG, SCHOTT AG, West Pharmaceutical Services, Ompi, Catalent, Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation & MedPro Inc.
MARKET SEGMENTATION
This research report on the Asia-Pacific prefilled syringes market has been segmented and sub-segmented into the following categories:
By Material
- Glass Prefilled Syringes
- Plastic Prefilled Syringes
By Type
- Conventional Prefilled Syringes
- Safety Prefilled Syringes
By Design
- Single-chamber
- Dual-chamber
By Application
- Vaccines
- Monoclonal Antibodies
By Distribution Channel
- Hospitals
- Ambulatory surgical centers
- Mail-order pharmacies
By Country
- India
- China
- Japan
- South Korea
- Australia
- New Zealand
- Thailand
- Malaysia
- Vietnam
- Philippines
- Indonesia
- Singapore
- Rest of Asia-Pacific